On September 9, 2024, Baltimore City Mayor Brandon M. Scott and the City of Baltimore announced they have reached an $80 million settlement with Teva Pharmaceuticals to resolve the City’s claims against Teva and its associated companies for their role in fueling Baltimore’s devastating opioid epidemic. Teva will make an initial payment of $35 million by year’s end and pay the remainder by July 1, 2025.

The City’s settlement with Teva is the fourth it has announced in connection with its ongoing litigation against the opioid distributors and manufacturers that fueled the worst opioid epidemic in the nation. It follows settlements with Allergan and CVS for $45 million each, as well as a $152.5 million settlement with Cardinal Health. This brings the City’s recoveries from opioid defendants to $322.5 million. The case against the remaining defendants, who made up over half the market share of the opioids that flooded Baltimore, were scheduled to proceed to trial on September 16, 2024.

As with the previous settlements, this settlement confirms the City’s decision to opt out of the national settlement with Teva has paid off. Under the terms of that settlement, the City would only have received $11 million paid over 13 years from Teva. Instead, in this settlement, the City will receive more than 7 times that amount in less than a year. In total, the City has now secured more than three times the total amount it would have received from all available global settlements with opioid defendants.

Per the agreement, the City will allocate $5 million for education and outreach efforts about the 988 system, $3 million to Penn North Recovery Center, and $2 million to BMore Power. The remainder of the funds will go through the process detailed in Mayor Scott’s executive order of August 29, 2024, which outlined a comprehensive framework for the administration of opioid restitution funds, in order to fight the ongoing opioid epidemic in Baltimore at all levels.

In announcing the settlement Mayor Scott stated: “”Nothing can undo the harm that they caused or bring back the lives lost, but we are determined to implement these resources in a way that helps move our City’s fight against this epidemic forward. It is my hope that these funds will help save lives and ensure that fewer families and communities have to endure the pain of losing loved ones to opioid overdose.”

The case is Mayor & City Council of Baltimore v. Purdue Pharma L.P., et al., 24-C-18-000515 in the Circuit Court of Maryland for Baltimore City.

Source

If you or a loved one may have been injured due to medical negligence in Baltimore, you should promptly consult with a Baltimore medical malpractice attorney (or a medical malpractice attorney elsewhere in Maryland or in another state) who may investigate your medical malpractice claim for you and represent you or a loved one in a medical negligence case, if appropriate.

Visit our website to be connected with medical malpractice lawyers in Baltimore or medical malpractice lawyers near you who may assist you with your medical malpractice claim, or call us toll free at 800-295-3959.

Turn to us when you don’t know where to turn.

Summary
$80 Million Opioid Settlement Reached Between Teva Pharmaceuticals And Baltimore City
Article Name
$80 Million Opioid Settlement Reached Between Teva Pharmaceuticals And Baltimore City
Description
On September 9, 2024, Baltimore City Mayor Brandon M. Scott and the City of Baltimore announced they have reached an $80 million settlement...
Author
Publisher Name
Medical Malpractice Lawyers
Publisher Logo